In addition, in pan-glioma analysis in TCGA microarray data set, HOXA5 also had the highest expression in patients without IDH mutation (P <0.001, respectively; Figure 4F), in patients without radiotherapy (P <0.001, respectively; Figure 4G). This evidence concerns the gene HOXA5 and central nervous system cancer.